| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |